McKesson Updates Fiscal Year 2026 Financial Outlook

The latest announcement is out from McKesson ( (MCK) ).

On June 9, 2025, McKesson Corporation announced updates to its Fiscal Year 2026 Financial Outlook, increasing its full year Adjusted Earnings per Diluted Share guidance and reaffirming its effective tax rate guidance. The company highlighted potential risks and uncertainties that could impact its financial performance, including legal disputes, cybersecurity incidents, and changes in healthcare laws, which stakeholders should consider.

The most recent analyst rating on (MCK) stock is a Hold with a $540.00 price target. To see the full list of analyst forecasts on McKesson stock, see the MCK Stock Forecast page.

Spark’s Take on MCK Stock

According to Spark, TipRanks’ AI Analyst, MCK is a Outperform.

McKesson’s overall score is driven by strong financial performance and positive earnings call outcomes, despite valuation concerns and balance sheet risks. Strategic acquisitions and a focus on core business segments bolster future growth prospects.

To see Spark’s full report on MCK stock, click here.

More about McKesson

McKesson Corporation operates in the healthcare industry, providing pharmaceuticals, medical supplies, and healthcare management tools. The company focuses on distributing pharmaceuticals and health information technology, with a significant emphasis on improving healthcare outcomes and operational efficiency.

Average Trading Volume: 1,053,674

Technical Sentiment Signal: Buy

Current Market Cap: $89.19B

Find detailed analytics on MCK stock on TipRanks’ Stock Analysis page.